Objective: To assess critically oritavancin, a second-generation lipoglycopeptide, for the treatment of Acute Bacterial Skin and Skin Structure Infections caused by susceptible Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus.
Aridis Pharmaceuticals announced top-line results from the AR-301-002 Phase III study, which evaluated the superiority of adjunctive use of the investigational monoclonal antibody candidate AR 301 (salvecin) with standard of care (SOC) antibiotics versus SOC antibiotics alone, for the treatment of VAP caused by Gram-positive bacteria Staphylococcus aureus (S. aureus).
Astellas and Theravance have received marketing authorisation from the European Commission for Vibativ (telavancin hydrochloride) for nosocomial pneumonia caused by...
In amyloid light chain (AL) amyloidosis, a small B-cell clone, most commonly a plasma cell clone, produces monoclonal light chains that exert organ toxicity and deposit in tissue in the form of amyloid fibrils.
The Advisory Committee (AIDAC) of the FDA has voted 9-6 that data, from Theravance relative to Vibativ (telavancin), failed to...
The elimination of nasal carriage of staphylococci, including methicillin resistant S taphylococcus aureus (MRSA).
Theravance Biopharma, Inc. announced new positive data from several studies of Vibativ (telavancin) confirming the product's in vitro potency against...
The FDA has approved Kimyrsa (oritavancin), from Melinta Therapeutics, for the treatment of adult patients with acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible isolates of designated Gram-positive microorganisms, including methicillin-resistant Staphylococcus aureus (MRSA).
Melinta Therapeutics announced that findings from the first phase of the ongoing Clinical and Historic Registry and Orbactiv Medical Evaluation...
Melinta Therapeutics, LLC announced that the FDA has approved Kimyrsa (oritavancin) for the treatment of adult patients with acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible isolates of designated Gram-positive microorganisms, including methicillin-resistant Staphylococcus aureus (MRSA).